Mechanisms of weight gain induced by antipsychotic drugs [1]

Journal of Clinical Psychiatry

Volumn 63, Issue 3, 2002, Pages 245-246

  Baptista, Trino ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; ESTRADIOL; GLUCOSE; HALOPERIDOL; INSULIN; LEPTIN; NEUROLEPTIC AGENT; OLANZAPINE; PHENOTHIAZINE; PIMOZIDE; PROGESTERONE; PROLACTIN; RISPERIDONE; SULPIRIDE; TAMOXIFEN; THIORIDAZINE; TRIFLUOPERAZINE;

ANOREXIA; DOPAMINE RELEASE; DOSE RESPONSE; DRUG RECEPTOR BINDING; FEEDING BEHAVIOR; FOOD INTAKE; GLUCOSE INTOLERANCE; HUMAN; HYPERPROLACTINEMIA; HYPOGONADISM; HYPOTHALAMUS; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEUS ACCUMBENS; OBESITY; OVARIECTOMY; PRIORITY JOURNAL; SCHIZOPHRENIA; SEX DIFFERENCE; WEIGHT GAIN;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; APPETITE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; HYPOTHALAMIC AREA, LATERAL; OBESITY; RATS; RATS, WISTAR; RISPERIDONE; SEX FACTORS; SULPIRIDE; WEIGHT GAIN;

EID: 0036109665     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (33)

1. The pharmacology of weight gain with antipsychotics
2. Weight gain from novel antipsychotic drugs: Need for action
3. Long-term adverse effects of novel antipsychotics
4. 2 dopamine receptors involved?
5. Puberty modifies sulpiride effects on body weight in rats
6. 2 antagonist sulpiride
7. Mechanism of the neuroleptic-induced obesity in rats
8. Amantadine in the treatment of neuroleptic-induced obesity in rats: Behavioral, endocrine and neurochemical correlates
9. Tamoxifen prevents sulpiride-induced weight gain in female rats
10. Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats
11. Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats
12. 2 satiety receptors in the body weight increase induced by systemic sulpiride
13. The effect of the dopamine receptor-blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man
14. Rats self-inject a dopamine antagonist in the lateral hypothalamus where it acts to increase extracellular dopamine in the nucleus accumbens
15. Mechanism of the body weight increase induced by systemic sulpiride
16. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy women: Relationship with body weight regulation
17. Antipsychotic drugs and reproductive hormones: Relationship to body weight regulation
18. Body weight gain after administration of antipsychotic drugs: Correlation with leptin, insulin and reproductive hormones
19. Endocrine and metabolic profile in the obesity associated to typical antipsychotic drug-administration
20. Regional obesity
21. Effects of the antipsychotic drug sulpiride on reproductive hormones in healthy men: Relationship with body weight regulation
22. Body weight gain induced by antipsychotic drugs: Mechanisms and management
23. Glucose tolerance and serum insulin levels in an animal model of obesity induced by sub-acute or chronic administration of antipsychotic drugs
24. Antipsychotic drug-induced obesity in rats: Correlation between leptin, insulin and body weight during sulpiride treatment
25. Insulin and leptin levels in patients with schizophrenia or related psychoses: A comparison between different antipsychotic agents
26. Why male rats do not gain weight after administration of antipsychotic drugs?
27. Naltrexone does not prevent the weight gain and hyperphagia induced by the antipsychotic drug sulpiride in rats
28. Clozapine and weight gain
29. Brain dopamine and obesity
30. Should the treatment of schizophrenia include old antipsychotic drugs?
31. 2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene
32. Antipsychotic-induced weight gain: A review of the literature